151 - 175 of 8587 Results
Title
Year
-
RESTRICTEDTitle: Genetic Testing for Parkinson DiseaseJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 1Start Page: 69End Page: 77Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000831Best OA location URL: https://cp.neurology.org/content/neurclinpract/11/1/69.full.pdfCitation Count: 23
- Lewy Body Disorders2017RESTRICTEDTitle: Lewy Body DisordersJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 35Issue #: 2Start Page: 325End Page: 338Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2017.01.004Best OA location URL: https://europepmc.org/articles/pmc5912679?pdf=renderCitation Count: 50
- A More Homogeneous Phenotype in Parkinson's Disease Related to R1441G Mutation in the LRRK2 Gene2021RESTRICTEDTitle: A More Homogeneous Phenotype in Parkinson's Disease Related to R1441G Mutation in the LRRK2 GeneJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.635396Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.635396/pdfCitation Count: 12
-
RESTRICTEDTitle: Early Dyskinesias in Parkinson’s Disease Patients With Parkin Mutation: A Primary Corticostriatal Synaptopathy?Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2019.00273Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2019.00273/pdfCitation Count: 9
-
RESTRICTEDTitle: Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA SymposiumJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.805135Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.805135/pdfCitation Count: 15
-
RESTRICTEDTitle: Current Directions in Deep Brain Stimulation for Parkinson’s Disease—Directing Current to Maximize Clinical BenefitJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 25End Page: 41Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-020-00181-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-020-00181-9.pdfCitation Count: 35
-
RESTRICTEDTitle: Clinical Use of On-Demand Therapies for Patients with Parkinson’s Disease and OFF PeriodsJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 12Issue #: 4Start Page: 1033End Page: 1049Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-023-00486-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-023-00486-5.pdfCitation Count: 2
-
RESTRICTEDTitle: Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 202End Page: 209Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.08.001Best OA location URL: https://europepmc.org/articles/pmc6037988?pdf=renderCitation Count: 74
-
RESTRICTEDTitle: Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 236End Page: 245Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.expneurol.2017.07.019Best OA location URL: https://doi.org/10.1016/j.expneurol.2017.07.019Citation Count: 128
-
RESTRICTEDTitle: Therapeutic approaches to target alpha-synuclein pathologyJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 225End Page: 235Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.expneurol.2017.10.003Best OA location URL: http://manuscript.elsevier.com/S0014488617302455/pdf/S0014488617302455.pdfCitation Count: 192
-
RESTRICTEDTitle: A comprehensive review of the diagnosis and treatment of Parkinson’s disease dysphagia and aspirationJournal Name: Expert Review of Gastroenterology & HepatologyPublisher: Informa UK LimitedVol: 14Issue #: 6Start Page: 411End Page: 424Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/17474124.2020.1769475Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405619Citation Count: 24
-
RESTRICTEDTitle: Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.00097Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.00097/pdfCitation Count: 67
-
RESTRICTEDTitle: Ten Unsolved Questions About Neuroinflammation in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 16End Page: 24Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28075Best OA location URL: https://inserm.hal.science/inserm-02568209/file/ReviewMDSinflammationRev11%20dgs%20eh.pdfCitation Count: 142
-
OPENTitle: 3D convolutional neural networks for classification of Alzheimer’s and Parkinson’s disease with T1-weighted brain MRIJournal Name: 17th International Symposium on Medical Information Processing and AnalysisPublisher: SPIEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1117/12.2606297Best OA location URL: https://doi.org/10.1101/2021.07.26.453903Citation Count: 1
-
RESTRICTEDTitle: Linking neuroscience with modern concepts of impulse control disorders in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 2Start Page: 141End Page: 149Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26068Best OA location URL: https://europepmc.org/articles/pmc4318759?pdf=renderCitation Count: 79
-
RESTRICTEDTitle: Vascular Parkinsonism: Deconstructing a SyndromeJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 886End Page: 894Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26263Best OA location URL: https://europepmc.org/articles/pmc4478160?pdf=renderCitation Count: 87
-
RESTRICTEDTitle: LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectivesJournal Name: Clinical Pharmacology: Advances and ApplicationsPublisher: Informa UK LimitedVol: Volume 8Issue #:Start Page: 177End Page: 189Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/cpaa.s102191Best OA location URL: https://www.dovepress.com/getfile.php?fileID=33080Citation Count: 41
-
RESTRICTEDTitle: Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairmentJournal Name: Human Brain MappingPublisher: WileyVol: 40Issue #: 18Start Page: 5424End Page: 5442Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/hbm.24782Best OA location URL: https://europepmc.org/articles/pmc6864887?pdf=renderCitation Count: 130
-
RESTRICTEDTitle: Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies – a mini reviewJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 32Issue #: 4Start Page: 291End Page: 297Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10286-022-00882-1Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101699Citation Count: 5
-
RESTRICTEDTitle: LRRK2 mutations and neurotoxicant susceptibilityJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 240Issue #: 6Start Page: 752End Page: 759Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1535370215579162Best OA location URL: https://europepmc.org/articles/pmc4935210?pdf=renderCitation Count: 28
-
RESTRICTEDTitle: At the dawn of the transcriptomic medicineJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 246Issue #: 3Start Page: 286End Page: 292Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1535370220954788Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876640Citation Count: 7
-
RESTRICTEDTitle: Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson’s diseaseJournal Name: Experimental & Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 47Issue #: 8Start Page: e179End Page: e179Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/emm.2015.54Best OA location URL: https://www.nature.com/articles/emm201554.pdfCitation Count: 27
-
RESTRICTEDTitle: Mitochondrial isolation: when size mattersJournal Name: Wellcome Open ResearchPublisher: F1000 Research LtdVol: 5Issue #:Start Page: 226End Page: 226Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.12688/wellcomeopenres.16300.2Best OA location URL: https://wellcomeopenresearch.org/articles/5-226/v2/pdfCitation Count: 4
-
RESTRICTEDTitle: Intracellular Thermometry at the Micro‐/Nanoscale and its Potential Application to Study Protein Aggregation Related to Neurodegenerative DiseasesJournal Name: ChemBioChemPublisher: WileyVol: 22Issue #: 9Start Page: 1546End Page: 1558Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/cbic.202000765Citation Count: 9
-
RESTRICTEDTitle: Recent Advances in the Development of Stem‐Cell‐Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1772End Page: 1780Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28628Citation Count: 34